Advertisement

Virchows Archiv B

, Volume 64, Issue 1, pp 281–286 | Cite as

Splenic haematopoiesis in primary (idiopathic) osteomyelofibrosis: immunohistochemical and morphometric evaluation of proliferative activity of erythro- and endoreduplicative capacity of megakaryopoiesis (PCNA- and Ki-67 staining)

  • Juergen Thiele
  • Frauke Gertrud Bennewitz
  • Hans Peter Bertsch
  • Stephan Falk
  • Robert Fischer
  • Hans-Jochen Stutte
Original Articles

Summary

Using monoclonal antibodies against proliferating cell nuclear antigen or PCNA (PC10) and the Ki-67 antigen (MIB1), an immunohistological and morphometric study was performed on routinely processed splenic tissue from ten patients with primary (idiopathic) osteomyelofibrosis (OMF). To determine the proliferation capacity of erythroid precursors and the endoreduplicative activity of megakaryocytes, corresponding antibodies (Ret40f and CD61) were applied in combination with the cell-cycle markers (sequential double-immunostaining). Morphometric analysis revealed no significant differences in PCNA or Ki-67 reactivity in either cell lineages. In comparison with previous studies on normal bone marrow, in splenic tissue showing myeloid metaplasia, the numbers of PCNA-labelled proerythroblasts, erythroblasts and megakaryocytes were conspicuously increased. Considering the ineffective erythropoiesis in OMF, there seemed to be a disproportional enhancement in PCNA and Ki-67 immunostaining of the red cell lineage. Similarly, the small size of megakaryocytes in advanced, OMF-associated myeloid metaplasia was in keeping with an impairment of endoreduplicative activity. In addition to various other contributory factors, anaemia in OMF may be partially caused by secondary folate (haematinic) deficiency. From experimental studies this defect is known to cause an abnormal arrest in the S-phase of the cell-cycle, comparable to that characterising pernicious anaemia. As a sequel of this pathomechanism, an undue overexpression of PCNA and Ki-67 has to be assumed, that is not necessarily associated with DNA synthesis or cell cycling.

Key words

Proliferating activity Erythroid precursors Megakaryocytes Spleen (myeloid metaplasia) PCNA Ki-67 Morphometry Primary (idiopathic) osteomyelofibrosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baserga R (1991) Growth regulation of the PCNA gene J Cell Sci 98:433–436PubMedGoogle Scholar
  2. Bernabei PA, Arcangeli A, Casini M, Grossi A, Padovani R, Rossi Ferrini P (1986) Platelet-derived growth factors(s) mitogenic activity in patients with myeloproliferative disease. Br J Haematol 63:353–357PubMedGoogle Scholar
  3. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363PubMedCrossRefGoogle Scholar
  4. Cohen MB, Waldman, FM, Carroll PR, Kerschmann R, Chew K, Mayall BH (1993) Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum Pathol 24:772–778PubMedCrossRefGoogle Scholar
  5. Cordell JL, Falini B, Erber WN, Gosh A, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229PubMedGoogle Scholar
  6. Dervan PA, Magee HM, Buckley C, Carney DN (1992) Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol 97 (Suppl 1):21–28Google Scholar
  7. Erber WN, Jacobs A, Oscier DC, O'Hea AM, Mason DJ (1987) Circulating micromegakaryocytes in myelodysplasia. J Clin Pathol 1349–1352Google Scholar
  8. Falk S, Mix D, Stutte HJ (1990) The spleen in osteomyelofibrosis: a morphological and immunohistochemical study of 30 cases. Virchows Archiv A Pathol Anat 416:437–442CrossRefGoogle Scholar
  9. Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DJ (1988) The immunohistomorphological detection of platelets megakaryocytes and thrombi in routinely processed specimens. Histopathology 13:257–267PubMedCrossRefGoogle Scholar
  10. Geary CG (1985) Clinical and hematological aspects of chronic myelofibrosis. In: Lewis SM (ed) Myelofibrosis, pathophysiology and clinical management. Decker, New York, pp. 15–49Google Scholar
  11. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867–873PubMedGoogle Scholar
  12. Gerdes J, Becker MHG, Key G (1992) Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 168:85–86PubMedCrossRefGoogle Scholar
  13. Golick ML, Rice M (1992) Optimum staining of PCNA in paraffin sections is dependent on fixation, drying, and intensification. J Histotechnol 15:39–41Google Scholar
  14. Guesdon JL, Ternynck T, Avrameas S (1987) The use of avidinbiotin interaction in immunoenzymatic technics. J Histochem Cytochem 27:1131–1139Google Scholar
  15. Hall PA, Levison DA, Wodds AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillet CE, Camplejohn R, Dover R, Waseem NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294PubMedCrossRefGoogle Scholar
  16. Hoffbrand AV, Chanarin I, Kremenchuzky S, Szur L, Waters AH, Mollin DL (1968) Megaloblastic anaemia in myelosclerosis. Q J Med 37:493–516Google Scholar
  17. Howarth JE, Waters HM, Hyde K, Geary CG (1989) Detection of erythroid hypoplasia in myelofibrosis using erythrokinetic studies. J Clin Pathol 42:1250–1252PubMedCrossRefGoogle Scholar
  18. Jaskulski D, Gatti C, Travali S, Calabretta B, Baserga R (1988) Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem 263:10175–10179PubMedGoogle Scholar
  19. Katoh O, Kimura A, Kuramoto A (1988) Platelet derived growth factor is decreased in patients with myeloproliferative disorders. Am J Hematol 27:276–280PubMedCrossRefGoogle Scholar
  20. Katoh O, Kimura A, Itoh T, Kuramoto A (1990) Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders. Am J Hematol 35:145–150PubMedCrossRefGoogle Scholar
  21. Keim DR, Hanash SM (1992) Proliferating cell nuclear antigen: a new marker of proliferation in cancer. Leuk Lymphoma 6:459–468CrossRefGoogle Scholar
  22. Key G, Becker MHG, Baron B, Durchow M, Schlüter C, Flad HD, Gerdes J (1993) New Ki-67-equivalent murine monoclonal antibodies (MIB1–3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629–636PubMedGoogle Scholar
  23. Kimura A, Katoh O, Kuramoto A (1988) Effects of platelet-derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br J Haematol 69:9–12PubMedCrossRefGoogle Scholar
  24. Kitagawa M, Kamiyama R, Kusuga T (1993) Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum Pathol 24:359–363PubMedCrossRefGoogle Scholar
  25. Levine RF, Hazzard KC, Lamberg JD (1982) The significance of magakaryocyte size. Blood 60:1122–1131PubMedGoogle Scholar
  26. Martyre MC (1991) Platelet PDGF and TGF-β: levels in myeloproliferative disorders. Leuk Lymphoma 6:1–6CrossRefGoogle Scholar
  27. McCarthy DM (1985) Fibrosis of the bone marrow: content and causes. Br J Haematol 59:1–7PubMedCrossRefGoogle Scholar
  28. McCormick D, Hall PA (1992) The complexities of proliferating cell nuclear antigen. Histopathology 21:591–594PubMedCrossRefGoogle Scholar
  29. McCormick D, Yu C, Hobbs C, Hall PA (1993) The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 22:543–547PubMedCrossRefGoogle Scholar
  30. Munakata S, Hendricks JB (1993) Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J. Histochem Cytochem 41:1241–1246PubMedGoogle Scholar
  31. Queisser U, Queisser W, Spiertz B (1971) Polyploidization of megakaryocytes in normal humans, in patients with idiopathic thrombocytopenia and with pernicious anaemia. Br J Haematol 20:489–501PubMedCrossRefGoogle Scholar
  32. Sabattini E, Gerdes J, Gherlinzoni F, Poggi S, Zucchini L, Melilli G, Grigioni F, Del Vecchio MT, Leoncini L, Falini B, Pileri S (1993) Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J Pathol 169:397–403PubMedCrossRefGoogle Scholar
  33. Sawhney N, Hall Pa (1992) Ki-67-structure, function, and new antibodies. J Pathol 168:161–162PubMedCrossRefGoogle Scholar
  34. Schwarting R (1993) Little missed markers and Ki-67. Lab Invest 68:597–599PubMedGoogle Scholar
  35. Scott RJ, Hall PA, Haldane JS, von Noorden S, Price Y, Lane DP, Wright NA (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165:173–178PubMedCrossRefGoogle Scholar
  36. Shi SR, Key MR, Kalra KL (1991) Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741–748PubMedGoogle Scholar
  37. Shivji MKK, Kenny MK, Wood RD (1992) Proliferating cell nuclear antigen (PCNA) is required for DNA excision repair. Cell 69:1–20CrossRefGoogle Scholar
  38. Stein H, Gatter KC, Asbahr H, Mason DY (1985) Methods in laboratory investigation, use of freeze-dried paraffin-embedded sections for immunhistologic staining with monoclonal antibodies. Lab Invest 52:676–683PubMedGoogle Scholar
  39. Thiele J, Fischer R (1991) Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. Virchows Archiv A Pathol Anat 418:81–97CrossRefGoogle Scholar
  40. Thiele J, Klein H, Falk S, Bertsch HP, Fischer R, Stutte HJ (1992) Splenic megakaryocytopoiesis in parimary (idiopathic) osteomyelofibrosis: an immunohistological and morphometric comparison of corresponding bone marrow features. Acta Haematol 87:176–180PubMedCrossRefGoogle Scholar
  41. Thiele J, Meuter RB, Titius RB, Zankovich R, Fischer R (1993) Proliferating cell nuclear antigen expression by erythroid precursors in normal human bone marrow, in reactive lesions and in polycythaemia rubra vera. Histopathology 22:429–435PubMedCrossRefGoogle Scholar
  42. Toschi L, Bravo R (1988) Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 107:1623–1628PubMedCrossRefGoogle Scholar
  43. Wickramasinghe SN, Cooper EH, Chalmers DG (1968) A study of erythropoiesis by combined morphologic, quantitative cytochemical and autoradiographic methods. Blood 31:304–313PubMedGoogle Scholar
  44. Wilkins BS, Harris S, Waseem NH, Lane DP, Jones DB (1992) A study of cell proliferation in formalin-fixed, waxembedded bone marrow trephine biopsies using the monoclonal antibody PC10, reactive with proliferating cell nuclear antigen (PCNA) J Pathol 166:45–52PubMedCrossRefGoogle Scholar
  45. Williams N, Levine RF (1982) The origin, development and regulation of megakaryocytes. Br J Haematol 52:173–180PubMedCrossRefGoogle Scholar
  46. Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65:803–809PubMedGoogle Scholar
  47. Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol 1:77–80PubMedGoogle Scholar
  48. Zhang B, Lewis SM (1989) The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity Eur J Haematol 43:63–66PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Juergen Thiele
    • 1
  • Frauke Gertrud Bennewitz
    • 1
  • Hans Peter Bertsch
    • 1
  • Stephan Falk
    • 2
  • Robert Fischer
    • 1
  • Hans-Jochen Stutte
    • 2
  1. 1.Institutes of PathologyUniversity of CologneCologneGermany
  2. 2.Johann-Wolfgang Goethe UniversityFrankfurt a. M.Germany

Personalised recommendations